LPT
GILD icon

Legacy Private Trust’s Gilead Sciences GILD Stock Holding History

Legacy Private Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$250K Sell
1,676
-491
-23% -$68.9K 0.01% 247
2026
Q2 		$274K Buy
2,167
+617
+40% +$81.3K 0.02% 237
2026
Q1 		$216K Buy
+1,550
New +$217K 0.01% 254
2016
Q4 		– Sell
-7,675
Closed -$607K – 243
2016
Q3 		$607K Sell
7,675
-8,081
-51% -$656K 0.08% 164
2016
Q2 		$1.31M Sell
15,756
-9,189
-37% -$815K 0.19% 115
2016
Q1 		$2.29M Buy
24,945
+215
+0.9% +$19.4K 0.35% 81
2015
Q4 		$2.5M Buy
24,730
+11,914
+93% +$1.24M 0.38% 73
2015
Q3 		$1.26M Buy
12,816
+776
+6% +$86.2K 0.2% 120
2015
Q2 		$1.41M Buy
12,040
+1,690
+16% +$185K 0.21% 118
2015
Q1 		$1.02M Hold
10,350
– – 0.15% 138
2014
Q4 		$976K Buy
10,350
+200
+2% +$20.7K 0.14% 149
2014
Q3 		$1.08M Sell
10,150
-150
-1% -$14.7K 0.17% 143
2014
Q2 		$854K Buy
+10,300
New +$802K 0.13% 149

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Legacy Private Trust's GILD Position: Q3 2026 in Review

Legacy Private Trust reduced its Gilead Sciences (GILD) stake by 23% in Q3 2026, selling an estimated $68.9K and leaving 1,676 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #247.

Legacy Private Trust first reported a position in GILD in Q2 2014 and has held it in 13 quarters since. The position peaked at $2.5M in Q4 2015. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Legacy Private Trust held 1,676 shares of Gilead Sciences worth $250K as of Q3 2026.
  • Legacy Private Trust sold 491 Gilead Sciences shares in Q3 2026, an estimated $68.9K.
  • Gilead Sciences made up 0.01% of Legacy Private Trust's portfolio in Q3 2026, its #247 holding.
  • Legacy Private Trust first reported a position in Gilead Sciences in Q2 2014 and has held it in 13 quarters since.
  • Legacy Private Trust's Gilead Sciences position peaked at $2.5M in Q4 2015.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Legacy Private Trust's 13F filing for Q3 2026, filed 6 Oct 2026.